Quick Answer
SI-BONE, Inc. reported Operating Income Loss of -$22.33 million for the year ending 2025.
- SI-BONE, Inc. showed an increase of +36.6% in Operating Income Loss from 2024 to 2025.
- This data is from SI-BONE, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$5.04 million | Q1 2018: -$2.92 million | Q2 2018: -$1.70 million | Q3 2018: -$3.04 million | Q1 2019: -$8.80 million | Q2 2019: -$8.14 million | Q3 2019: -$10.58 million | Q1 2020: -$11.88 million | Q2 2020: -$10.14 million | Q3 2020: -$8.68 million | Q1 2021: -$11.58 million | Q2 2021: -$12.97 million | Q3 2021: -$13.20 million | Q1 2022: -$16.87 million | Q2 2022: -$17.88 million | Q3 2022: -$13.57 million | Q1 2023: -$11.29 million | Q2 2023: -$11.96 million | Q3 2023: -$11.17 million | Q1 2024: -$12.04 million | Q2 2024: -$10.08 million | Q3 2024: -$7.63 million | Q1 2025: -$7.48 million | Q2 2025: -$7.00 million | Q3 2025: -$5.38 million.
- Over the full 9 years of available data (2017 to 2025), SI-BONE, Inc.'s Operating Income Loss has declined by 28.7%.
- Historical annual values: Fiscal year 2025: -$22.33 million | Fiscal year 2024: -$35.25 million | Fiscal year 2023: -$46.93 million | Fiscal year 2022: -$59.61 million | Fiscal year 2021: -$51.67 million | Fiscal year 2020: -$38.57 million | Fiscal year 2019: -$36.00 million | Fiscal year 2018: -$11.97 million | Fiscal year 2017: -$17.35 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: